Patents by Inventor Taylor John Eddens

Taylor John Eddens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of pneumocystis antigens and uses thereof
    Patent number: 10596237
    Abstract: Pneumonia due to the fungus Pneumocystis jirovecii is a life-threatening infection that occurs in immunocompromised patients. The inability to culture the organism as well as the lack of a sequenced genome has hindered antigen discovery that could be useful in developing effective vaccines, therapeutic antibodies and diagnostic methods. A method of surface proteomics of Pneumocystis murina that reliably detects surface proteins that are conserved in Pneumocystis jirovecii is described. In particular, eight identified P. murina surface proteins are described. Methods of eliciting immune responses against the identified proteins, generating therapeutic antibodies against the identified proteins, as well as diagnostic methods based on the identified peptides are described.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: March 24, 2020
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, University of New Orleans, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jay Kennedy Kolls, Mingquan Michael Zheng, Yang Cai, Taylor John Eddens, David M. Ricks
  • IDENTIFICATION OF PNEUMOCYSTIS ANTIGENS AND USES THEREOF
    Publication number: 20170173126
    Abstract: Pneumonia due to the fungus Pneumocystis jirovecii is a life-threatening infection that occurs in immunocompromised patients. The inability to culture the organism as well as the lack of a sequenced genome has hindered antigen discovery that could be useful in developing effective vaccines, therapeutic antibodies and diagnostic methods. A method of surface proteomics of Pneumocystis murina that reliably detects surface proteins that are conserved in Pneumocystis jirovecii is described. In particular, eight identified P. murina surface proteins are described. Methods of eliciting immune responses against the identified proteins, generating therapeutic antibodies against the identified proteins, as well as diagnostic methods based on the identified peptides are described.
    Type: Application
    Filed: March 19, 2015
    Publication date: June 22, 2017
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, University of New Orleans, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jay Kennedy Kolls, Mingquan Michael Zheng, Yang Cai, Taylor John Eddens, David M. Ricks